Cambridge scientists develop repurposed liver drug to combat Covid-19
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.
The Covid-19 virus, in some of the British patients discharged from hospitals, has led to lung damage which is irreversible and may get.
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million
Removing gender inequalities on women’s HIV risks can help end the AIDS pandemic, according to UNAIDS.
A breakthrough new bandage design utilizing microgels can help heal wounds faster.
The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed “a substantial risk with.